• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.

作者信息

Wong Vincent Wai-Sun, Chan Wah-Kheong, Chitturi Shiv, Chawla Yogesh, Dan Yock Young, Duseja Ajay, Fan Jiangao, Goh Khean-Lee, Hamaguchi Masahide, Hashimoto Etsuko, Kim Seung Up, Lesmana Laurentius Adrianto, Lin Yu-Cheng, Liu Chun-Jen, Ni Yen-Hsuan, Sollano Jose, Wong Simon Kin-Hung, Wong Grace Lai-Hung, Chan Henry Lik-Yuen, Farrell Geoff

机构信息

Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Shatin, Hong Kong.

State Key Laboratory of Digestive Disease and Department of Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong.

出版信息

J Gastroenterol Hepatol. 2018 Jan;33(1):70-85. doi: 10.1111/jgh.13857.

DOI:10.1111/jgh.13857
PMID:28670712
Abstract
摘要

相似文献

1
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.2017年亚太地区非酒精性脂肪性肝病工作小组指南 - 第1部分：定义、危险因素及评估
J Gastroenterol Hepatol. 2018 Jan;33(1):70-85. doi: 10.1111/jgh.13857.
2
The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.《2017年亚太地区非酒精性脂肪性肝病工作组指南 - 第2部分：管理与特殊群体》
J Gastroenterol Hepatol. 2018 Jan;33(1):86-98. doi: 10.1111/jgh.13856.
3
Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines.亚太地区的非酒精性脂肪性肝病：定义及拟议指南概述
J Gastroenterol Hepatol. 2007 Jun;22(6):778-87. doi: 10.1111/j.1440-1746.2007.05001.x.
4
Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.评估中国代谢综合征与肝活检证实的非酒精性脂肪性肝炎之间的关系：一项多中心横断面研究设计
Adv Ther. 2016 Nov;33(11):2069-2081. doi: 10.1007/s12325-016-0416-4. Epub 2016 Oct 14.
5
How should we manage patients with non-alcoholic fatty liver disease in 2007?2007年我们应该如何管理非酒精性脂肪性肝病患者？
J Gastroenterol Hepatol. 2007 Jun;22(6):801-8. doi: 10.1111/j.1440-1746.2007.04977.x.
6
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis.当前非酒精性脂肪性肝病管理指南：系统评价与比较分析。
World J Gastroenterol. 2018 Aug 14;24(30):3361-3373. doi: 10.3748/wjg.v24.i30.3361.
7
New trends on obesity and NAFLD in Asia.亚洲肥胖和非酒精性脂肪性肝病的新趋势。
J Hepatol. 2017 Oct;67(4):862-873. doi: 10.1016/j.jhep.2017.06.003. Epub 2017 Jun 19.
8
How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?非酒精性脂肪性肝病在亚太地区的发病率如何，是否存在地区差异？
J Gastroenterol Hepatol. 2007 Jun;22(6):788-93. doi: 10.1111/j.1440-1746.2007.05042.x.
9
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?亚太地区非酒精性脂肪性肝病的风险因素及相关情况有哪些？
J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. doi: 10.1111/j.1440-1746.2007.04952.x. Epub 2007 May 13.
10
Nonalcoholic fatty liver disease in Asia: emerging perspectives.亚洲的非酒精性脂肪性肝病：新视角。
J Gastroenterol. 2017 Feb;52(2):164-174. doi: 10.1007/s00535-016-1264-3. Epub 2016 Sep 16.

引用本文的文献

1
Correlation of intestinal bacteria, fungi and dietary nutrient intake in NAFLD patients with spleen deficiency syndrome.非酒精性脂肪性肝病脾虚证患者肠道细菌、真菌与膳食营养摄入的相关性
Front Cell Infect Microbiol. 2025 Aug 11;15:1586212. doi: 10.3389/fcimb.2025.1586212. eCollection 2025.
2
MAFLD was more easily diagnosed than NAFLD in liver transplant recipients with abnormal liver function.在肝功能异常的肝移植受者中，MAFLD比NAFLD更容易诊断。
ILIVER. 2022 Sep 20;1(3):194-198. doi: 10.1016/j.iliver.2022.09.001. eCollection 2022 Sep.
3
KRT23 as a Potential Target for Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): Evidence From Bioinformatics Analysis, Human Gene Polymorphism and Animal Experiments.
角蛋白23作为代谢功能障碍相关脂肪性肝病（MAFLD）的潜在靶点：来自生物信息学分析、人类基因多态性和动物实验的证据
Int J Gen Med. 2025 Jun 3;18:2807-2821. doi: 10.2147/IJGM.S520326. eCollection 2025.
4
Cardiometabolic risk in non-diabetic metabolic dysfunction-associated steatotic liver disease (MAFLD) patients: insights from the triglyceride-glucose, plasma atherogenic, and cardiometabolic index.非糖尿病性代谢功能障碍相关脂肪性肝病（MAFLD）患者的心脏代谢风险：来自甘油三酯-葡萄糖、血浆致动脉粥样硬化和心脏代谢指数的见解
Arch Med Sci. 2024 Jul 25;21(2):401-408. doi: 10.5114/aoms/190867. eCollection 2025.
5
Diagnostic Value of Serum Cytokeratin 18 for the Staging of Liver Inflammation and Fibrosis: A Meta-Analysis.血清细胞角蛋白18对肝脏炎症和纤维化分期的诊断价值：一项荟萃分析。
J Clin Lab Anal. 2025 Apr;39(8):e70034. doi: 10.1002/jcla.70034. Epub 2025 Apr 9.
6
Triglyceride-glucose index is independently associated with fatty pancreas disease in Chinese elderly.甘油三酯-葡萄糖指数与中国老年人的脂肪性胰腺疾病独立相关。
BMC Endocr Disord. 2025 Mar 18;25(1):74. doi: 10.1186/s12902-025-01900-9.
7
Association of concomitant MASLD and hepatitis B virus with clinical prognosis in hepatocellular carcinoma after curative resection.根治性切除术后肝细胞癌患者中，合并代谢相关脂肪性肝病（MASLD）和乙型肝炎病毒感染与临床预后的关系
Am J Cancer Res. 2025 Feb 15;15(2):737-748. doi: 10.62347/KSLN5850. eCollection 2025.
8
The external validation of Dallas Steatosis Index among Asian population: a useful tool for metabolic dysfunction-associated steatotic liver disease identification and prevention.达拉斯脂肪变性指数在亚洲人群中的外部验证：一种用于识别和预防代谢功能障碍相关脂肪性肝病的有用工具。
J Gastroenterol. 2025 May;60(5):621-631. doi: 10.1007/s00535-025-02220-4. Epub 2025 Feb 24.
9
Selenium Nanoparticles Decorated With Stevioside Potentially Attenuate Fructose Palmitate Induced Lipid Accumulation in HepG2 Cells.甜菊糖苷修饰的硒纳米颗粒可能减轻果糖棕榈酸酯诱导的HepG2细胞脂质积累。
Mediators Inflamm. 2025 Feb 13;2025:7942947. doi: 10.1155/mi/7942947. eCollection 2025.
10
Design and rationale for a global novel non-invasive screening observational study using genetics and non-invasive methodologies to identify at-risk MASLD participants: The ALIGN study.一项利用遗传学和非侵入性方法识别高危非酒精性脂肪性肝病（MASLD）参与者的全球新型非侵入性筛查观察性研究的设计与原理：ALIGN研究
Contemp Clin Trials Commun. 2025 Jan 20;44:101437. doi: 10.1016/j.conctc.2025.101437. eCollection 2025 Apr.